World Cardiac Marker Tests Clinical Pipeline Research Report 2023: Analysis of Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

News provided by

Jan 17, 2024, 12:30 ET

DUBLIN, Jan. 17, 2024 /PRNewswire/ -- The "Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Cardiac Marker Tests Pipeline Report provides comprehensive information about the Cardiac Marker Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. A cardiac marker test is a biomarker test used to diagnosis cardiac diseases.

The comprehensive report delves deeply into the realm of Cardiac Marker Tests, offering extensive coverage of the ongoing developments in this critical healthcare sector. It meticulously reviews the intricate details of major pipeline products, encompassing comprehensive product descriptions, licensing agreements, collaborative efforts, and other pivotal developmental activities shaping the landscape of cardiac marker tests.

Moreover, the report conducts a thorough examination of the major players actively driving innovation in Cardiac Marker Tests, presenting a comprehensive catalog of their ongoing pipeline projects. This coverage spans the entire spectrum of development stages, ranging from early conceptualization to products in the approved and issued stages, providing a holistic view of the evolving field of cardiac marker tests.

Additionally, the report provides crucial clinical trial data related to ongoing trials linked to these pipeline products, ensuring stakeholders are well-informed about the latest advancements in this critical sector. It also keeps a keen eye on recent developments within the cardiac marker tests segment and the broader industry, ensuring that stakeholders stay up-to-date with the latest trends and breakthroughs.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Marker Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Cardiac Marker Tests Overview

3 Products under Development
3.1 Cardiac Marker Tests - Pipeline Products by Stage of Development
3.2 Cardiac Marker Tests - Pipeline Products by Segment
3.3 Cardiac Marker Tests - Pipeline Products by Territory
3.4 Cardiac Marker Tests - Pipeline Products by Regulatory Path
3.5 Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
3.6 Cardiac Marker Tests - Ongoing Clinical Trials

4 Cardiac Marker Tests - Pipeline Products under Development by Companies
4.1 Cardiac Marker Tests Companies - Pipeline Products by Stage of Development
4.2 Cardiac Marker Tests - Pipeline Products by Stage of Development

5 Cardiac Marker Tests Companies and Product Overview

6 Cardiac Marker Tests - Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

1Drop Diagnostics
3PrimeDx, Inc.
A/C Diagnostics LLC
Abbott Diagnostics
Abbott Point of Care Inc
Abionic SA
Accel Diagnostics LLC
Access Bio Inc
ACS Biomarker
Adaltis Srl
AgPlus Diagnostics LTD
Akrivis Technologies LLC
Alere Inc
Alfa Wassermann Diagnostic Technologies, LLC
Alfa Wassermann Inc
All India Institute of Medical Sciences
Angle Biosciences Inc
Anteo Technologies Pty Ltd
Applied Proteomics Inc
Arrayit Corp (Inactive)
Arterez LLC
Aspira Womens Health Inc
Astute Medical Inc
Aterovax SA
Atonomics A/S (Inactive)
Axis-Shield Diagnostics Ltd
AXO Science SAS
Baker IDI Heart and Diabetes Institute
Baylor College of Medicine
BBB Technologies Inc
Beckman Coulter Inc
Behavioral Diagnostics Inc
Berg LLC
Bertis Inc
BG Medicine Inc
Bio Preventive Medicine Corp
Bio-AMD Inc
BioMedomics Inc
bioMerieux SA
Biosensia Ltd
Biostealth, Inc.
Biosurfit, SA
Biouniversa srl
Bluejay Diagnostics Inc
Boditech Med Inc
Boston Children's Hospital
British Heart Foundation
Canon Medical Systems Corp
Carclo Diagnostic Solutions Ltd
CardiNor AS
CardioGenics Inc
Cardior Pharmaceuticals GmbH
Carmel Diagnostics Ltd
Cavadis BV
Cedars-Sinai Medical Center
Cellgenex Diagnostics
ChemImage Corp
China Medical Technologies Inc (Inactive)
China Sky One Medical Inc
CHIP Diagnostics Inc
Cleveland Clinic
Co-Diagnostics Inc
Cordex Systems, LLC
Corgenix Medical Corp
CPD, LLC
Critical Diagnostics
DestiNA Genomics Ltd
Diagnorite Innovative Healthcare Pvt Ltd
Diagnos Inc
Diazyme Laboratories Inc
Diomune SL
DSC Technologies Inc
Duke University
Edan Instruments Inc
Edan Medical
ELITechGroup Inc
Emory University
Endothelium Scanning Nanotechnology Ltd
Epinex Diagnostics Inc
ET Healthcare Inc
Firalis SAS
Flinders University
French National Institute of Health and Medical Research
G Medical Health and Wellness
genedrive plc
Genesis Detection Systems, Inc.
Global Genomics Group LLC
GlyCardial Diagnostics SL
Grifols SA
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
Handok-Kalos Medical
Hannover Medical School
HealthCheck Diagonstics Inc
Hemex Health Inc
Hunan Lezhun Zhixin Biotechnology Co Ltd
Infigo Diagnostics Ltd (Inactive)
Inflammatix Inc
infYnity biomarkers S.A.S.
Insilicos LLC
Institute of Metabolic and Cardiovascular Diseases
Intelligent Optical Systems, Inc.
iXensor Co. Ltd.
Johns Hopkins University
Joslin Diabetes Center
KineMed Inc
Laboratory Corp of America Holdings
LeukoDx Ltd
LightDeck Diagnostics Inc
LumiraDx Ltd
MagBiosense Inc
Magnisense SAS
Mayo Clinic
MDNA Life Sciences Inc
Mediomics, LLC
MedMira Inc
Merck Millipore Corp
MetaboGen AB
Metanomics Health GmbH
MiRXES Pte Ltd
MML Ltd
MyCartis NV
Mylab Discovery Solutions Pvt Ltd
Nanomix Inc
Nanosphere Inc (Inactive)
National Center for Cardiovascular Research Carlos III
Neuome Peptides Pte Ltd
Nirmidas Biotech Inc
NorthShore University Health System
Nuclea Biotechnologies Inc. (Inactive)
Numares AG
Ohmx Corp
OPKO Health Inc
Orbit Genetics Inc
Ortho Clinical Diagnostics Holdings Plc
OSLER Diagnostics Ltd
Paperdrop Diagnostics SL
Parque Cientifico de Madrid
Persuasive BV
PixCell Medical Technologies Ltd
Prevencio Inc
Prognosys LLC
Prolight Diagnostics AB
Prolocor Inc.
Proplex Technologies Llc
Propria LLC
Proteome Sciences Plc
Proxim Diagnostics Corp
Psyros Diagnostics Ltd
Pulmokine Inc
QLIDA Diagnostics
Queen's University Belfast
Quidel Corp
Radiometer Medical ApS
Radisens Diagnostics Ltd
Randox Laboratories Ltd
Resdin Technologies Inc.
Rheonix Inc
Roche Diagnostics International Ltd
ROS Technologies, Inc
Salignostics Ltd
Sandia National Laboratories
Sarissa-Biomedical Ltd
SDIX LLC
Selfa, Inc.
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shineco Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthineers AG
Singulex Inc
SomaLogic Inc
Soroka University Medical Center
Sphingotec GmbH
SpinChip Diagnostics AS
Sree Chitra Tirunal Institute for Medical Sciences & Technology
StageZero Life Sciences Ltd
T2 Biosystems Inc
Tcoag Us Inc
Tethys Bioscience Inc (Inactive)
The Centre of Excellence for Prevention of Organ Failure
The University of British Columbia
Thermo Fisher Scientific Inc
ThreeFold Sensors (Inactive)
Tosoh Bioscience Inc
Trinity Biotech Plc
U.S. Department of Veterans Affairs
UpFront Diagnostics Ltd
Upstream Medical Technologies Ltd
vall d hebron institut de Recerca
Vega Russia
Washington University School of Medicine
XCellCure, LLC
Zymo Research Corp

For more information about this report visit https://www.researchandmarkets.com/r/1pjzri

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets